Table 1 Participant characteristics
Participant number | Group allocation | Gender | Age | BMI | IPAQ | Duration of symptoms (months) | Prior history | Worst NPRS at time of entry to pilot study |
|---|---|---|---|---|---|---|---|---|
2 | Intervention | Female | 41 | 29.2 | Moderate | 10 | No | 4 |
4 | Intervention | Male | 28 | 22.59 | Moderate | 24 | No | 4 |
7 | Intervention | Female | 56 | 25.85 | Moderate | 18 | No | 6 |
8 | Intervention | Male | 43 | 21.03 | Moderate | 3.5 | Yes | 4 |
10 | Intervention | Female | 52 | 40.56 | Moderate | 7.5 | No | 9 |
11 | Intervention | Female | 44 | 20.78 | Moderate | > 24 | No | 5 |
23 | Intervention | Female | 35 | 20.76 | Moderate | 3 | No | 3 |
24 | Intervention | Male | 48 | 24.49 | High | 7 | No | 8 |
29 | Intervention | Female | 44 | 27.48 | High | 14 | No | 8 |
13 | Control | Male | 45 | 24.98 | High | 3.5 | No | 3 |
15 | Control | Female | 44 | 29.75 | Low | 11 | No | 4 |
17 | Control | Male | 37 | 25.22 | High | 3 | Yes | 8 |
20 | Control | Female | 50 | 22.31 | Moderate | 4 | No | 5 |
22 | Control | Female | 43 | 26.93 | Moderate | 3.5 | No | 5 |
26 | Control | Female | 45 | 20.38 | High | 18 | No | 8 |
30 | Control | Male | 58 | 32.87 | High | 36 | No | 7 |